Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastatic × palbociclib × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 170 Neoplasm Metastasis 18 Ovarian Neoplasms 7 Neoplasms 7 Breast Diseases 6 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms by Site 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Advanced Breast Cancer 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Neoplasm, Residual 2 Lung Neoplasms 2 Inflammation 2 Hereditary Sensory and Autonomic Neuropathies 2 Fallopian Tube Neoplasms 2 Estrogen Receptor-positive Breast Cancer 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Cardiovascular Diseases 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Brain Neoplasms 2 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1

Interventions

Fulvestrant 5 Letrozole 4 exemestane 3 Capecitabine 3 Anastrozole 3 ribociclib 2 dalpiciclib 2 apatinib 2 Trastuzumab 2 Gemcitabine 2 Docetaxel 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 pyrotinib 1 patritumab deruxtecan 1 palbociclib 1 olaparib 1 nirogacestat 1 margetuximab 1 irinotecan sucrosofate 1 fluzoparib 1 abemaciclib 1 Zoledronic Acid 1 Vinorelbine 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Ga(III)-DOTATOC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03322215 2024-03-08

PASIPHAE

Karolinska University Hospital

Phase 2 Terminated

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡